> Evotec has signed a deal with Germany's Eternygen to team up on small-molecule drugs for metabolic diseases. More
> Debiopharm is partnering with Yale University to use the school's computer-aided drug discovery methods. News
> Evotec has signed a deal with Germany's Eternygen to team up on small-molecule drugs for metabolic diseases. More
> Debiopharm is partnering with Yale University to use the school's computer-aided drug discovery methods. News